Skip to main content
Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern,
Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern, - Direktorin des Instituts für Zelluläre Neurowissenschaften II am UKB, sind Sprecher und stellvertretende Sprecherin der neuen DFG-Forschungsgruppe FOR 5987. Der Forschungsverbund untersucht, wie Botenstoffe Informationen im Gehirn innerhalb und außerhalb von Synapsen übertragen.
© Foto: UKB/Annika Breuer

News categories: Honors & Funding

How Far Do Signalling Molecules Act Beyond the Boundaries of a Synapse?

The German Research Foundation (DFG) is establishing a new Research Unit entitled “Inside and Outside the Synapse: Challenging Dogmas of Synaptic Signalling and Neuromodulation.” The research consortium is headed by Prof. Christian Henneberger from Bonn University Hospital (UKB) and the University of Bonn, with Prof. Susanne Schoch McGovern, also from the UKB and the University of Bonn, serving as deputy spokesperson. Together with researchers from the UKB, the University of Bonn, the German Center for Neurodegenerative Diseases (DZNE) and the University of Göttingen, they will investigate how signalling molecules transmit information in the brain, both within and beyond synapses. The first funding period will run for four years.

Prof. Christian Henneberger, Director of the Institute of Cellular Neurosciences I at the UKB, and Prof. Susanne Schoch McGovern, Director of the Institute of Cellular Neurosciences II at the UKB, are spokesperson and deputy spokesperson of the new DFG Research Unit FOR 5987. The research consortium investigates how signalling molecules transmit information in the brain within and beyond synapses. © Photo: UKB/Annika Breuer

Nerve cells communicate using signalling molecules. According to the traditional view, these molecules either act very specifically at individual contact points between nerve cells, known as synapses, or spread across larger areas of brain tissue in a process known as volume transmission. The newly established research unit challenges this clear distinction and assumes that there are gradual transitions between the two forms of signalling.

Using the signalling molecule glutamate and the neuromodulators dopamine and noradrenaline as examples, the researchers want to investigate how neural tissue distributes and filters information spatially and translates it into neuronal activity. Their work will focus on the hippocampus and prefrontal cortex.

“We want to understand how neurons and glial cells actually communicate within the densely packed tissue of the brain. In doing so, we are moving away from the idea that each synapse operates independently,” says Prof. Henneberger, spokesperson of the research unit, Director of the Institute of Cellular Neurosciences I at the UKB and a member of the Transdisciplinary Research Area “Life & Health” at the University of Bonn. “I hope that the close collaboration within the research unit will allow us to develop a much more realistic picture of how signalling molecules distribute information in the brain and how this gives rise to complex brain functions.”

New methods make spatial communication visible

To quantitatively measure the spread and effects of signalling molecules, the research unit will combine newly developed optical sensors with high- and super-resolution microscopy, electron microscopy, AI-assisted protein engineering and mathematical modelling. This will allow the researchers to investigate how far signalling molecules spread through neural tissue, which cellular structures they act on and how this influences the function of neuronal networks.

In the long term, the findings could also contribute to a better understanding of neurological and neurodegenerative diseases. Many of these conditions are associated with changes in synapses, glial cells and the structure of brain tissue. However, little is currently known about whether these changes also affect the spatial range and precision of signalling. The research unit aims to provide important fundamental insights in this area.

Research consortium from Bonn and Göttingen

The research unit brings together Prof. Sandra Blaess, Prof. Dirk Dietrich, PD Dr. Gregor Hagelueken, Prof. Christian Henneberger, Prof. Susanne Schoch McGovern and Prof. Tatjana Tchumatchenko from Bonn University Hospital and the University of Bonn; Prof. Martin Fuhrmann, Dr. Sabine Krabbe and Prof. Gabor Petzold from the German Center for Neurodegenerative Diseases (DZNE) in Bonn; and Prof. U. Valentin Nägerl from the University of Göttingen. Prof. Christian Henneberger is spokesperson of the research unit, with Prof. Susanne Schoch McGovern serving as deputy spokesperson.

Contact
Prof. Dr. Christian Henneberger
Institute of Cellular Neurosciences I
Bonn University Hospital (UKB) and Transdisciplinary Research Area “Life & Health”, University of Bonn
Email: christian.henneberger@uni-bonn.de

Related news

Sieglinde Tyczka und Frederick Tyczka-Christoph zu Besuch in der Bonner Universitäts-Augenklinik. - von links: Prof. Dr. Uwe Reuter, Vorstandsvorsitzender und Ärztlicher Vorstand des UKB, Frederick Tyczka-Christoph, Sieglinde Tyczka, Prof. Dr. Frank G. Holz, Direktor der Augenklinik am UKB.

News categories: Honors & Funding

One Million Euros for Restoring Vision in Age-Related Macular Degeneration

The Tyczka family of entrepreneurs is supporting research into restoring vision in patients with age-related macular degeneration (AMD) with a donation of one million euros. The funding will support the research project “AI-supported optimisation of vision restoration using retinal implants” at the Department of Ophthalmology at Bonn University Hospital (UKB). The aim of the project is to further develop and optimise the application of innovative retinal implant technology, which recently received European CE marking as a medical device.
View entry
25 Millionen Euro für die Bonner KI-Krebsforschung: (v.l.) Prof. Dr. Bernd Weber, Prof. Dr. Michael Hölzel, Prof. Dr. Jürgen Bajorath und Prof. Dr. Uwe Reuter, beim Auftakt von AI4CancerCure.NRW in der Staatskanzlei Nordrhein-Westfalen.

News categories: Honors & Funding

€25 Million for AI-Powered Cancer Research in Bonn

University Hospital Bonn (UKB), the University of Bonn and the Lamarr Institute for Machine Learning and Artificial Intelligence are using funding from the state of North Rhine-Westphalia to establish a joint research infrastructure. The aim is to use AI to design and optimize potential cancer therapeutics and subsequently test them in the laboratory. Minister-President Hendrik Wüst and Minister of Science Ina Brandes presented the funding commitment today at the State Chancellery of North Rhine-Westphalia.
View entry
Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry

Back to the news overview